You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oncopeptides has received a research grant of 3 million SEK from Sweden's Innovation Agency (Vinnova), to explore the development of new treatment options for glioblastoma, an aggressive and incurable form of brain cancer. The grant enables exploratory research to better understand the potential Already a subscriber Login You have read…
OxThera has recently been granted two new US patents, three new Europeanpatents and patents in Canada, China, Hong-Kong, India and Japan. OxThera now holds proprietary rights to pharmaceutical preparations and their use for treatment of hyperoxaluria in nine patent families. The Already a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of this content.…
The two companies have executed a master services agreement (MSA) to initiate projects in the pre-clinical early development space. The aim with the agreement is to solve the challenge of poor bioavailability and solubility in new drug candidates. “Wider uptake of the latest technological innoAlready a subscriber Login You have…
Novo Nordisk has announced the launch of a new social responsibility strategy, Defeat Diabetes. The strategy strengthens Novo Nordisk’s commitment and introduces new long-term ambitions to provide access to affordable diabetes care to vulnerable patients in every country and to ensure that no cAlready a subscriber Login You have read…
